Cargando…
Management of COVID-19-related immune thrombocytopenia by rhTPO
Autores principales: | Zhang, Xuzhao, Li, Min, Chen, Tao, Lv, Dong, Xia, Pengfei, Qian, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478614/ https://www.ncbi.nlm.nih.gov/pubmed/34462401 http://dx.doi.org/10.5045/br.2021.2020049 |
Ejemplares similares
-
A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
por: Zhu, Qiuhua, et al.
Publicado: (2021) -
A Randomized Controlled Study of rhTPO and rhIL-11 for the Prophylactic Treatment of Chemotherapy-Induced Thrombocytopenia in Non-Small Cell Lung Cancer
por: Xu, Yunhua, et al.
Publicado: (2018) -
rhTPO Ameliorates Radiation-Induced Long-Term Hematopoietic Stem Cell Injury in Mice
por: Luan, Hao, et al.
Publicado: (2023) -
The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial)
por: Zhou, Zhigang, et al.
Publicado: (2019) -
rhTPO combined with chemotherapy and G-CSF for autologous peripheral blood stem cells in patients with refractory/relapsed non-Hodgkin’s lymphoma
por: Zhu, Jun, et al.
Publicado: (2019)